Buscar Co Stock Price, News & Analysis

Buscar Company (OTC: CGLD) is a diversified holding company headquartered in Beverly Hills, California. According to company disclosures, Buscar focuses on three main areas: natural resources, sustainable technologies, and pharmaceuticals and nutraceuticals. The company’s structure centers on operating and majority-owned subsidiaries that each pursue distinct but complementary business lines.

Buscar trades on the OTC market under the symbol CGLD. The company describes itself as having evolved through a strategic transformation that included a reverse merger with Eon Discovery Inc. in 2020. Through this evolution, Buscar has built a portfolio that spans gold mining, hemp-based bioplastics, and natural health and antiviral products.

Natural resources: Eon Discovery and Treasure Canyon

In the natural resources segment, Buscar oversees Eon Discovery Inc., a wholly owned subsidiary that manages gold mining operations in California’s Plumas National Forest. Eon Discovery controls the Treasure Canyon Gold Mine property in Plumas County, California, covering approximately 200 acres and including 10 Bureau of Land Management mining claims within the Plumas National Forest.

The Treasure Canyon project has been the subject of extensive geological and technical work. Company news describes a comprehensive geological report by Mars Mines Ltd. that characterizes the deposit as an Iron Oxide Copper-Gold (IOCG) style mineral system, with associations of gold, copper, and other metals. Buscar, through Eon Discovery, has also engaged Mother Lode Mining and Qualified Geologists to prepare technical reports under NI 43-101 and to support SEC-compliant Regulation S-K 1300 reporting for the project.

Press releases describe a completed NI 43-101 Technical Report for a U.S. California mining project and, separately, a NI 43-101 report for the Treasure Canyon Gold Mine in Plumas County. These reports discuss Proven and Probable Reserves, continuous alluvial channels over the 200-acre site, and gravity-based extraction concepts. The company has also highlighted proprietary technologies such as the Plasma Extractor System (PES), designed to recover monoatomic and colloidal gold from black sands, and metallurgical testing that supports high recovery rates through reagent-free gravity concentration. In addition, Buscar has referenced environmental reclamation efforts, including mercury remediation and riparian habitat restoration, managed under the Lori Jane Foundation.

In a later update, Buscar announced a strategic evaluation plan for the Treasure Canyon Gold Mine, emphasizing systematic review of historical mining records, assessment of existing infrastructure, and preliminary exploration activities such as detailed site assessments, baseline studies, geophysical surveys, and evaluation of adjacent properties. The company notes that any further exploration or development is subject to funding, regulatory approvals (including BLM permits and environmental clearances), and suitable field conditions. Buscar has also indicated that it is pursuing engagement of a new independent Qualified Person under S-K 1300 to review and verify prior technical work and to prepare a technical report summary.

Company communications caution that historical estimates and production records for Treasure Canyon are not compliant with S-K 1300 standards and should not be relied upon as indicators of current mineral resources or reserves as defined under S-K 1300.

Sustainable technologies: Terramer Inc. and hemp-based bioplastics

In sustainable technologies, Buscar has acquired a 50% stake in Terramer Inc. via a stock swap. Terramer is described as a pioneer in hemp-based biodegradable bioplastics. Its flagship product, TERBO-1000, is presented as a proprietary hemp-based bioplastic that is fully biodegradable within a defined period and designed to leave no microplastic residue.

According to Terramer-focused disclosures, the company operates a large production facility and targets the bioplastics market by supplying material for sectors such as packaging, food service, automotive, and construction. Terramer’s strategy includes scaling production, using an AI-driven Terramer Designer Space for custom formulations, and exploring carbon credit monetization tied to lifecycle emissions reductions. Buscar’s ownership interest in Terramer is positioned as part of its diversification into green technologies that address plastic pollution.

Pharmaceuticals and nutraceuticals: Armorgenix

In the pharmaceutical and nutraceutical segment, Buscar has acquired a 70% stake in Armorgenix through a stock swap. Armorgenix is described as a Wyoming-based innovator in natural health and pharmaceutical technologies, with operations and plans that include enzyme-based therapies, compounded natural remedies, detoxification solutions, and antiviral products.

Company releases highlight DetoxShield, a clinically evaluated detoxification product, as part of Armorgenix’s portfolio. Armorgenix focuses on detoxification and antiviral solutions and is positioned to serve the U.S. antiviral and detoxification markets. Plans described by the company include establishing a Texas-based manufacturing facility and a Wyoming-based corporation to manage intellectual property, research, and a brand tailored for North American markets. Armorgenix is also associated with enzyme therapy, clinical nutrition, and natural health approaches that complement conventional medicine.

Buscar has announced leadership appointments at Armorgenix, noting that the subsidiary’s management will oversee daily operations, strategic planning, product development, and expansion of manufacturing capabilities. The company positions Armorgenix as a key growth driver within its diversified portfolio.

Corporate strategy and reporting ambitions

Buscar consistently describes itself as a diversified holding company that integrates natural resources, sustainable technologies, and pharmaceuticals. Its communications emphasize a strategy of growth through targeted acquisitions and development of high-potential assets in these sectors. The company cites Eon Discovery’s mining operations, Terramer’s hemp-based bioplastics, and Armorgenix’s detoxification and antiviral products as core components of this approach.

On the corporate governance and capital markets side, Buscar has issued multiple updates about its efforts to become a fully reporting company with the U.S. Securities and Exchange Commission and to pursue an uplisting to the OTCQX Market. The company reports that it has filed fiscal year financial statements on OTC Markets, engaged Barton CPA PLLC, a PCAOB-registered public accounting firm, to conduct a comprehensive audit, and retained specialized SEC legal counsel to prepare and file a Form 10.

These steps are described as part of a broader plan to enhance transparency, align with SEC reporting standards, and meet the financial and governance requirements associated with the OTCQX tier. Buscar states that these initiatives are intended to improve market visibility and support its long-term growth objectives.

Environmental and ESG considerations

Buscar’s disclosures around the Treasure Canyon project and Terramer’s bioplastics emphasize environmental and ESG themes. For Treasure Canyon, the company references mercury remediation, riparian habitat restoration, zero-discharge water management, native species revegetation, and community job creation, coordinated with the Lori Jane Foundation and in compliance with relevant federal and state regulations. For Terramer, the focus is on hemp-based bioplastics that are designed to biodegrade without leaving microplastic residue, contributing to efforts to reduce plastic pollution.

In its communications, Buscar presents these environmental and social elements as integral to its approach to resource development and sustainable technologies.

Business model and segments

Based on company statements, Buscar’s business model is organized around three principal segments:

• Natural resources – Managed primarily through Eon Discovery Inc. and centered on the Treasure Canyon Gold Mine and other gold mining claims in California’s Plumas National Forest.
• Sustainable technologies – Represented by its 50% stake in Terramer Inc., focusing on hemp-based biodegradable bioplastics and related sustainable materials.
• Pharmaceuticals and nutraceuticals – Driven by its majority stake in Armorgenix, which concentrates on detoxification products, antiviral solutions, enzyme therapies, and natural health-oriented pharmaceutical offerings.

Buscar’s communications describe these holdings as complementary, with natural resources providing an asset foundation, sustainable materials addressing environmental concerns, and pharmaceuticals targeting health-related needs.

Regulatory and technical reporting

For investors following regulatory and technical documentation, Buscar highlights several frameworks and standards relevant to its operations. In mining, the company references NI 43-101 technical reports and Regulation S-K 1300 for SEC-compliant disclosure of mineral projects. It has engaged Qualified Geologists and Qualified Persons to prepare and validate technical reports for Treasure Canyon and related projects, and has discussed plans to prepare technical report summaries in accordance with Item 1300 of Regulation S-K.

On the corporate reporting side, Buscar’s work with Barton CPA PLLC and SEC legal counsel is aimed at producing audited financial statements and a Form 10 registration statement to achieve fully reporting status under SEC rules.

FAQs about Buscar Company (CGLD)